Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (141-150 of 467) with videos related to

Pageof 47
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 1, 2014
[Gene expression classifiers in the prognosis of breast cancer]Caroline A Drukker, Marjanka K Schmidt, Thijs van Dalen, et al.
The Journal of Pathology|April 9, 2009
Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancerMarleen Kok, Rutger H Koornstra, Tania C Margarido, et al.
International Journal of Cancer|February 7, 2014
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapyKarin Beelen, Laurien D C Hoefnagel, Mark Opdam, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 11, 2009
Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometryS F Teunissen, H Rosing, R H T Koornstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profileN Feller, K Hoekman, C M Kuiper, et al.
Health Policy (Amsterdam, Netherlands)|May 26, 2026
Coverage with evidence development programs: a scoping review on characteristics and patient accessJoost G E Verbeek, Rianne L Seefat, Erica A Wilthagen, et al.
Breast Cancer Research and Treatment|April 29, 2014
Prognostic factors for survival in metastatic breast cancer by hormone receptor statusA B G Kwast, A C Voogd, M B E Menke-Pluijmers, et al.
Cancer Reports (Hoboken, N.J.)|June 19, 2021
Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapyEvert S M van Aken, Aart Beeker, Ilse Houtenbos, et al.
Plos One|August 2, 2014
Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastasesMarieke A Vollebergh, Christiaan Klijn, Philip C Schouten, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Adjuvant chemotherapy in small node-negative triple-negative breast cancerTessa G Steenbruggen, Erik van Werkhoven, Mette S van Ramshorst, et al.
Pageof 47

Showing results (141-150 of 467) with videos related to

Sort By:
Pageof 47
Nederlands Tijdschrift Voor Geneeskunde|May 1, 2014
[Gene expression classifiers in the prognosis of breast cancer]Caroline A Drukker, Marjanka K Schmidt, Thijs van Dalen, et al.
The Journal of Pathology|April 9, 2009
Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancerMarleen Kok, Rutger H Koornstra, Tania C Margarido, et al.
International Journal of Cancer|February 7, 2014
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapyKarin Beelen, Laurien D C Hoefnagel, Mark Opdam, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 11, 2009
Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometryS F Teunissen, H Rosing, R H T Koornstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profileN Feller, K Hoekman, C M Kuiper, et al.
Health Policy (Amsterdam, Netherlands)|May 26, 2026
Coverage with evidence development programs: a scoping review on characteristics and patient accessJoost G E Verbeek, Rianne L Seefat, Erica A Wilthagen, et al.
Breast Cancer Research and Treatment|April 29, 2014
Prognostic factors for survival in metastatic breast cancer by hormone receptor statusA B G Kwast, A C Voogd, M B E Menke-Pluijmers, et al.
Cancer Reports (Hoboken, N.J.)|June 19, 2021
Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapyEvert S M van Aken, Aart Beeker, Ilse Houtenbos, et al.
Plos One|August 2, 2014
Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastasesMarieke A Vollebergh, Christiaan Klijn, Philip C Schouten, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Adjuvant chemotherapy in small node-negative triple-negative breast cancerTessa G Steenbruggen, Erik van Werkhoven, Mette S van Ramshorst, et al.
Pageof 47